VYNE Therapeutics Inc
(NASDAQ:VYNE)
$3.90
-0.11[-2.74%]
Last update: 6:55PM (Delayed 15-Minutes)
Get Real Time Here
$3.90
0[0.00%]
Open4.150Close4.040
Vol / Avg.11.525K / 15.621KMkt Cap12.792M
Day Range3.920 - 4.29352 Wk Range2.034 - 8.730

VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary

VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.

Open4.150Close4.040
Vol / Avg.11.525K / 15.621KMkt Cap12.792M
Day Range3.920 - 4.29352 Wk Range2.034 - 8.730
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Pharmaceuticals

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-1.990-2.820 -0.8300
REV100.000K135.000K35.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains28.0028.00
2023-05-12Cantor FitzgeraldLouise ChenMaintainsOverweightRaises5.009.00
2023-05-12HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains-28.00
2023-04-19HC Wainwright & Co.Joseph PantginisReiteratesBuyMaintains-28.00

Related Companies

TickerCompanyChg %Mkt Cap
VYNEVYNE Therapeutics-2.74%12.8M
CINGCingulate-4.14%12M
ITRMIterum Therapeutics15.24%10.4M
COCPCocrystal Pharma5.13%20.9M
ONTXOnconova Therapeutics5.76%16M
Q

How do I buy VYNE Therapeutics (VYNE) stock?

A

You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VYNE Therapeutics's (VYNE) competitors?

Q

What is the target price for VYNE Therapeutics (VYNE) stock?

A

The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for VYNE Therapeutics (VYNE)?

A

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.

Q

Does VYNE Therapeutics (VYNE) pay a dividend?

A

There is no dividend information for VYNE Therapeutics.

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A

VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is VYNE Therapeutics (VYNE) going to split?

A

There is no upcoming split for VYNE Therapeutics.

Q

What sector and industry does VYNE Therapeutics (VYNE) operate in?

A

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary

VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.

Open4.150Close4.040
Vol / Avg.11.525K / 15.621KMkt Cap12.792M
Day Range3.920 - 4.29352 Wk Range2.034 - 8.730
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Pharmaceuticals

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-1.990-2.820 -0.8300
REV100.000K135.000K35.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains28.0028.00
2023-05-12Cantor FitzgeraldLouise ChenMaintainsOverweightRaises5.009.00
2023-05-12HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains-28.00
2023-04-19HC Wainwright & Co.Joseph PantginisReiteratesBuyMaintains-28.00

Related Companies

TickerCompanyChg %Mkt Cap
VYNEVYNE Therapeutics-2.74%12.8M
CINGCingulate-4.14%12M
ITRMIterum Therapeutics15.24%10.4M
COCPCocrystal Pharma5.13%20.9M
ONTXOnconova Therapeutics5.76%16M
Q

How do I buy VYNE Therapeutics (VYNE) stock?

A

You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VYNE Therapeutics's (VYNE) competitors?

Q

What is the target price for VYNE Therapeutics (VYNE) stock?

A

The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for VYNE Therapeutics (VYNE)?

A

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.

Q

Does VYNE Therapeutics (VYNE) pay a dividend?

A

There is no dividend information for VYNE Therapeutics.

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A

VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is VYNE Therapeutics (VYNE) going to split?

A

There is no upcoming split for VYNE Therapeutics.

Q

What sector and industry does VYNE Therapeutics (VYNE) operate in?

A

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary

VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.

Open4.150Close4.040
Vol / Avg.11.525K / 15.621KMkt Cap12.792M
Day Range3.920 - 4.29352 Wk Range2.034 - 8.730
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Pharmaceuticals

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-1.990-2.820 -0.8300
REV100.000K135.000K35.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains28.0028.00
2023-05-12Cantor FitzgeraldLouise ChenMaintainsOverweightRaises5.009.00
2023-05-12HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains-28.00
2023-04-19HC Wainwright & Co.Joseph PantginisReiteratesBuyMaintains-28.00

Related Companies

TickerCompanyChg %Mkt Cap
VYNEVYNE Therapeutics-2.74%12.8M
CINGCingulate-4.14%12M
ITRMIterum Therapeutics15.24%10.4M
COCPCocrystal Pharma5.13%20.9M
ONTXOnconova Therapeutics5.76%16M
Q

How do I buy VYNE Therapeutics (VYNE) stock?

A

You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VYNE Therapeutics's (VYNE) competitors?

Q

What is the target price for VYNE Therapeutics (VYNE) stock?

A

The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for VYNE Therapeutics (VYNE)?

A

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.

Q

Does VYNE Therapeutics (VYNE) pay a dividend?

A

There is no dividend information for VYNE Therapeutics.

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A

VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is VYNE Therapeutics (VYNE) going to split?

A

There is no upcoming split for VYNE Therapeutics.

Q

What sector and industry does VYNE Therapeutics (VYNE) operate in?

A

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary

VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.

Open4.150Close4.040
Vol / Avg.11.525K / 15.621KMkt Cap12.792M
Day Range3.920 - 4.29352 Wk Range2.034 - 8.730
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Pharmaceuticals

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-1.990-2.820 -0.8300
REV100.000K135.000K35.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains28.0028.00
2023-05-12Cantor FitzgeraldLouise ChenMaintainsOverweightRaises5.009.00
2023-05-12HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains-28.00
2023-04-19HC Wainwright & Co.Joseph PantginisReiteratesBuyMaintains-28.00

Related Companies

TickerCompanyChg %Mkt Cap
VYNEVYNE Therapeutics-2.74%12.8M
CINGCingulate-4.14%12M
ITRMIterum Therapeutics15.24%10.4M
COCPCocrystal Pharma5.13%20.9M
ONTXOnconova Therapeutics5.76%16M
Q

How do I buy VYNE Therapeutics (VYNE) stock?

A

You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VYNE Therapeutics's (VYNE) competitors?

Q

What is the target price for VYNE Therapeutics (VYNE) stock?

A

The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for VYNE Therapeutics (VYNE)?

A

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.

Q

Does VYNE Therapeutics (VYNE) pay a dividend?

A

There is no dividend information for VYNE Therapeutics.

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A

VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is VYNE Therapeutics (VYNE) going to split?

A

There is no upcoming split for VYNE Therapeutics.

Q

What sector and industry does VYNE Therapeutics (VYNE) operate in?

A

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary

VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.

Open4.150Close4.040
Vol / Avg.11.525K / 15.621KMkt Cap12.792M
Day Range3.920 - 4.29352 Wk Range2.034 - 8.730
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Pharmaceuticals

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-1.990-2.820 -0.8300
REV100.000K135.000K35.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains28.0028.00
2023-05-12Cantor FitzgeraldLouise ChenMaintainsOverweightRaises5.009.00
2023-05-12HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains-28.00
2023-04-19HC Wainwright & Co.Joseph PantginisReiteratesBuyMaintains-28.00

Related Companies

TickerCompanyChg %Mkt Cap
VYNEVYNE Therapeutics-2.74%12.8M
CINGCingulate-4.14%12M
ITRMIterum Therapeutics15.24%10.4M
COCPCocrystal Pharma5.13%20.9M
ONTXOnconova Therapeutics5.76%16M
Q

How do I buy VYNE Therapeutics (VYNE) stock?

A

You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VYNE Therapeutics's (VYNE) competitors?

Q

What is the target price for VYNE Therapeutics (VYNE) stock?

A

The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for VYNE Therapeutics (VYNE)?

A

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.

Q

Does VYNE Therapeutics (VYNE) pay a dividend?

A

There is no dividend information for VYNE Therapeutics.

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A

VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is VYNE Therapeutics (VYNE) going to split?

A

There is no upcoming split for VYNE Therapeutics.

Q

What sector and industry does VYNE Therapeutics (VYNE) operate in?

A

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary

VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.

Open4.150Close4.040
Vol / Avg.11.525K / 15.621KMkt Cap12.792M
Day Range3.920 - 4.29352 Wk Range2.034 - 8.730
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Pharmaceuticals

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-1.990-2.820 -0.8300
REV100.000K135.000K35.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains28.0028.00
2023-05-12Cantor FitzgeraldLouise ChenMaintainsOverweightRaises5.009.00
2023-05-12HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains-28.00
2023-04-19HC Wainwright & Co.Joseph PantginisReiteratesBuyMaintains-28.00

Related Companies

TickerCompanyChg %Mkt Cap
VYNEVYNE Therapeutics-2.74%12.8M
CINGCingulate-4.14%12M
ITRMIterum Therapeutics15.24%10.4M
COCPCocrystal Pharma5.13%20.9M
ONTXOnconova Therapeutics5.76%16M
Q

How do I buy VYNE Therapeutics (VYNE) stock?

A

You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VYNE Therapeutics's (VYNE) competitors?

Q

What is the target price for VYNE Therapeutics (VYNE) stock?

A

The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for VYNE Therapeutics (VYNE)?

A

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.

Q

Does VYNE Therapeutics (VYNE) pay a dividend?

A

There is no dividend information for VYNE Therapeutics.

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A

VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is VYNE Therapeutics (VYNE) going to split?

A

There is no upcoming split for VYNE Therapeutics.

Q

What sector and industry does VYNE Therapeutics (VYNE) operate in?

A

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary

VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.

Open4.150Close4.040
Vol / Avg.11.525K / 15.621KMkt Cap12.792M
Day Range3.920 - 4.29352 Wk Range2.034 - 8.730
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Pharmaceuticals

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-1.990-2.820 -0.8300
REV100.000K135.000K35.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains28.0028.00
2023-05-12Cantor FitzgeraldLouise ChenMaintainsOverweightRaises5.009.00
2023-05-12HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains-28.00
2023-04-19HC Wainwright & Co.Joseph PantginisReiteratesBuyMaintains-28.00

Related Companies

TickerCompanyChg %Mkt Cap
VYNEVYNE Therapeutics-2.74%12.8M
CINGCingulate-4.14%12M
ITRMIterum Therapeutics15.24%10.4M
COCPCocrystal Pharma5.13%20.9M
ONTXOnconova Therapeutics5.76%16M
Q

How do I buy VYNE Therapeutics (VYNE) stock?

A

You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VYNE Therapeutics's (VYNE) competitors?

Q

What is the target price for VYNE Therapeutics (VYNE) stock?

A

The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for VYNE Therapeutics (VYNE)?

A

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.

Q

Does VYNE Therapeutics (VYNE) pay a dividend?

A

There is no dividend information for VYNE Therapeutics.

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A

VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is VYNE Therapeutics (VYNE) going to split?

A

There is no upcoming split for VYNE Therapeutics.

Q

What sector and industry does VYNE Therapeutics (VYNE) operate in?

A

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary

VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.

Open4.150Close4.040
Vol / Avg.11.525K / 15.621KMkt Cap12.792M
Day Range3.920 - 4.29352 Wk Range2.034 - 8.730
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Pharmaceuticals

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-1.990-2.820 -0.8300
REV100.000K135.000K35.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains28.0028.00
2023-05-12Cantor FitzgeraldLouise ChenMaintainsOverweightRaises5.009.00
2023-05-12HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains-28.00
2023-04-19HC Wainwright & Co.Joseph PantginisReiteratesBuyMaintains-28.00

Related Companies

TickerCompanyChg %Mkt Cap
VYNEVYNE Therapeutics-2.74%12.8M
CINGCingulate-4.14%12M
ITRMIterum Therapeutics15.24%10.4M
COCPCocrystal Pharma5.13%20.9M
ONTXOnconova Therapeutics5.76%16M
Q

How do I buy VYNE Therapeutics (VYNE) stock?

A

You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VYNE Therapeutics's (VYNE) competitors?

Q

What is the target price for VYNE Therapeutics (VYNE) stock?

A

The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for VYNE Therapeutics (VYNE)?

A

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.

Q

Does VYNE Therapeutics (VYNE) pay a dividend?

A

There is no dividend information for VYNE Therapeutics.

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A

VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is VYNE Therapeutics (VYNE) going to split?

A

There is no upcoming split for VYNE Therapeutics.

Q

What sector and industry does VYNE Therapeutics (VYNE) operate in?

A

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

VYNE Therapeutics Stock (NASDAQ:VYNE), Quotes and News Summary

VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.

Open4.150Close4.040
Vol / Avg.11.525K / 15.621KMkt Cap12.792M
Day Range3.920 - 4.29352 Wk Range2.034 - 8.730
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Pharmaceuticals

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-1.990-2.820 -0.8300
REV100.000K135.000K35.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-14HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains28.0028.00
2023-05-12Cantor FitzgeraldLouise ChenMaintainsOverweightRaises5.009.00
2023-05-12HC Wainwright & Co.Joseph PantginisReiteratesBuyBuyMaintains-28.00
2023-04-19HC Wainwright & Co.Joseph PantginisReiteratesBuyMaintains-28.00

Related Companies

TickerCompanyChg %Mkt Cap
VYNEVYNE Therapeutics-2.74%12.8M
CINGCingulate-4.14%12M
ITRMIterum Therapeutics15.24%10.4M
COCPCocrystal Pharma5.13%20.9M
ONTXOnconova Therapeutics5.76%16M
Q

How do I buy VYNE Therapeutics (VYNE) stock?

A

You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are VYNE Therapeutics's (VYNE) competitors?

Q

What is the target price for VYNE Therapeutics (VYNE) stock?

A

The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Monday, August 14, 2023. The analyst firm set a price target for 28.00 expecting VYNE to rise to within 12 months (a possible 617.95% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for VYNE Therapeutics (VYNE)?

A

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $3.9 last updated September 29, 2023 at 10:55 PM UTC.

Q

Does VYNE Therapeutics (VYNE) pay a dividend?

A

There is no dividend information for VYNE Therapeutics.

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A

VYNE Therapeutics’s Q3 earnings are confirmed for Thursday, November 9, 2023.

Q

Is VYNE Therapeutics (VYNE) going to split?

A

There is no upcoming split for VYNE Therapeutics.

Q

What sector and industry does VYNE Therapeutics (VYNE) operate in?

A

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.